IFI-B · Glycoalkaloid Reduction Series

Specimen SS-F-BTR-603 // ZERO-BITTER · IFI-B

Glycoalkaloid · T1 Biolistic-A

Solanum tuberosum

Potato

Tier IGlycoalkaloid Reduction Series

Target Trait

45%

% reduction

Solanine/chaconine reduction

Technical Specifications

SKU

SS-F-BTR-603

Genomic Edits

4

GC Content

46.3%

Construct Length

2,802 bp

Promoter System

UBI-1 / 35S CaMV

Expression System

Biolistic particle bombardment

Host Strain

Gold particle 0.6 µm

Receptor Target

TAS2R38 (suppression)

IFI Score

45

Pathway Edits

  • SGT1 solanidine glucosyltransferase RNAi blocks galactosylation step in α-solanine terminal glycosylation
  • SGT3 solanidine glucosyltransferase RNAi eliminates rhamnose addition step in α-chaconine pathway
  • GAME12 RNAi suppresses solanidine-to-tomatidine conversion branch that generates chaconine precursors
  • GAME4 modification reduces overall steroidal alkaloid pathway throughput at the cycloartenol-to-solanidine axis

Key Interventions

SGT1 galactosyltransferase RNAiSGT3 rhamnosyltransferase silencingGAME12 suppression

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
45
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier I Solanum tuberosum lines with reduced glycoalkaloid content for fresh-market potato production, potato-derived food ingredients, and breeding programs targeting improved consumer palatability and regulatory compliance with glycoalkaloid thresholds.

License

$299 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Zero-Bitter · IFI-BAll Modalities